Skip to main content
SpringerLink
Log in

„Treat-to-target (T2T)“ Empfehlungen für die Behandlung von Patienten mit Spondyloarthritis – Übersetzung ins Deutsche

Treat-to-target (T2T) recommendation for patients with spondyloarthritis – translation into German

  • Originalien
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

Zusammenfassung

Das Management von Patienten mit Spondyloarthritiden (SpA) hat in den letzten Jahren einen Paradigmenwechsel erlebt. Dies gilt sowohl für die Behandlung der axialen als auch der peripheren Manifestationen. Basierend auf der Treat-to-target(T2T)-Strategie sind für die SpA nun ebenfalls internationale T2T-Empfehlungen publiziert worden, die neben 15 Empfehlungen auch fünf übergeordnete Prinzipien (A–E) enthalten. Um die Empfehlungen bekannt zu machen und die nationale Verbreitung zu fördern, haben deutsche Experten eine Übersetzung der T2T-Empfehlungen für SpA ins Deutsche erstellt.

Abstract

The management of patients with spondyloarthritis (SpA) has experienced a paradigm shift in recent years. This is true for the treatment of axial as well as peripheral manifestations. International treat to target (T2T) recommendations for SpA based on the T2T strategy have now also been published, which contain 5 higher level principles (A–E) in addition to the 15 recommendations. In order to make the recommendations known and to promote national distribution, German experts have now issued a translation of the T2T recommendations for SpA into German.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

axSpA:

Axiale SpA

AS:

Ankylosierende Spondylitis

ASAS:

Assessment of SpondyloArthritis International Society

ASDAS:

AS Disease Activity Score

nr-axSpA:

Nicht-röntgenologische axSpA

NRS:

Numerische Rating-Skala

PsA:

Psoriasisarthritis

RA:

Rheumatoide Arthritis

SI-Gelenke:

Sakroiliakalgelenke

SpA:

Spondyloarthritiden

SLR:

Systematische Literatursuche

T2T:

Treat-to-target

Literatur

  1. Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377(9783):2127–2137

    Article  PubMed  Google Scholar 

  2. Rudwaleit M, Heijde D van der, Landewe R, Listing J, Akkoc N, Brandt J et al (2009) The development of Assessment of Spondylo Arthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777–783

    Article  CAS  PubMed  Google Scholar 

  3. Vander CB, Ribbens C, Boonen A, Mielants H, Vlam K de, Lenaerts J et al (2007) The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Ann Rheum Dis 66(8):1072–1077

    Article  Google Scholar 

  4. Rudwaleit M, Heijde D van der, Landewe R, Akkoc N, Brandt J, Chou CT et al (2011) The Assessment of Spondylo Arthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25–31

    Article  CAS  PubMed  Google Scholar 

  5. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673

    Article  PubMed  Google Scholar 

  6. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631–637

    Article  PubMed  PubMed Central  Google Scholar 

  7. Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P et al (2014) Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 73(1):6–16. doi:10.1136/annrheumdis-2013-203419

    Article  PubMed  Google Scholar 

  8. Schoels MM, Braun J, Dougados M, Emery P, Fitzgerald O, Kavanaugh A et al (2014) Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis. Ann Rheum Dis 73(1):238–242. doi:10.1136/annrheumdis-2013-203860

    Article  CAS  PubMed  Google Scholar 

  9. Helliwell PS, Mease PJ, FitzGerald O, Taylor WJ, Heijde D van der (2013) Peripheral spondyloarthritis and psoriatic arthritis; overlaps and distinctions: a report from the GRAPPA 2012 annual meeting. J Rheumatol 40(8:1446–1449

    Article  Google Scholar 

  10. Braun J, Sieper J (2013) Remission and possible discontinuation of biological therapy in axial spondyloarthritis. Clin Exp Rheumatol 31(4 Suppl 78):S33–S36

    PubMed  Google Scholar 

  11. Sieper J (2012) How to define remission in ankylosing spondylitis? Ann Rheum Dis 71(Suppl 2):i93–i95

    Article  PubMed  Google Scholar 

  12. Heijde D van der, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68(12):1811–1818

    Article  PubMed  Google Scholar 

  13. Machado P, Landewe RB, Braun J, Baraliakos X, Hermann KG, Hsu B et al (2012) MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor. Ann Rheum Dis 71(12):2002–2005

    Article  PubMed  Google Scholar 

  14. Ramiro S, Heijde D van der, Tubergen A van, Stolwijk C, Dougados M, Bosch F van den et al (2014) Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis 73(8):1455–1461

    Article  PubMed  Google Scholar 

  15. Coates LC, Moverley AR, McParland L, Brown S, Navarro-Coy N, O’Dwyer JL et al (2015) Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. Lancet 386(10012):2489–2498. doi:10.1016/S0140-6736(15)00347-5

    Article  PubMed  PubMed Central  Google Scholar 

  16. Coates LC, Helliwell PS (2010) Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data. Arthritis Care Res (Hoboken) 62(7):965–969

    Article  Google Scholar 

  17. Mease PJ (2011) Psoriatic arthritis: update on pathophysiology, assessment and management. Ann Rheum Dis 70(Suppl 1):i77–84

    Article  PubMed  Google Scholar 

  18. Husic R, Gretler J, Felber A, Graninger WB, Duftner C, Hermann J et al (2014) Disparity between ultrasound and clinical findings in psoriatic arthritis. Ann Rheum Dis 73(8):1529–1536

    Article  PubMed  Google Scholar 

  19. Aydin SZ, Karadag O, Filippucci E, Atagunduz P, Akdogan A, Kalyoncu U et al (2010) Monitoring Achilles enthesitis in ankylosing spondylitis during TNF-alpha antagonist therapy: an ultrasound study. Rheumatology (Oxford) 49(3):578–582

    Article  CAS  Google Scholar 

  20. Heijde D van der, Braun J, Deodhar A, Inman RD, Xu S, Mack ME et al (2013) Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE). Rheumatology (Oxford) 52(2):321–325

    Article  Google Scholar 

  21. Mandl P, Navarro-Compan V, Terslev L, Aegerter P, Heijde D van der, D’Agostino MA et al (2015) EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 74(7):1327–1339

    Article  CAS  PubMed  Google Scholar 

  22. Bakewell CJ, Olivieri I, Aydin SZ, Dejaco C, Ikeda K, Gutierrez M et al (2013) Ultrasound and magnetic resonance imaging in the evaluation of psoriatic dactylitis: status and perspectives. J Rheumatol 40(12):1951–1957

    Article  PubMed  Google Scholar 

Download references

Danksagung

Xenofon Baraliakos, Jan Brandt, Adrian Cíurea, Winfried Graninger Michael Hammer, Herbert Kellner, Klaus Krüger, Jens Kuipers, Heinz-Jürgen Lakomek, Bernhard Manger, Wilfried Mau, Kurt Redlich, Michael Schirmer, Josef Smolen, Ulrich Weber.

Author information

Authors and Affiliations

  1. Rheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649, Herne, Deutschland

    U. Kiltz & J. Braun

  2. Campus Benjamin Franklin, Charité Berlin, Hindenburgdamm 30, 12203, Berlin, Deutschland

    J. Sieper, B. Buss & H. Haíbel

  3. Park-Klinik Weissensee, Berlin, Deutschland

    M. Backhaus

  4. Deutsche Rheuma-Liga, Maximilianstr. 14, 53111, Bonn, Deutschland

    E. Gromnica-Ihle

  5. Deutsche Vereinigung Morbus Bechterew e. V., Metzgergasse 16, 97421, Schweinfurt, Deutschland

    L. Hammel

  6. Praxis für Rheumatologie und Innere Medizin, Schlosstrasse 110, Berlin, Deutschland

    K. Karberg

  7. Agaplesion Markus Krankenhaus, Klinik für Orthopädie und Unfallchirurgie, Wilhelm-Epstein Str. 4, Frankfurt, Deutschland

    S. Rehart

  8. Klinikum Bielefeld Rosenhöhe, Bielefeld, Deutschland

    M. Rudwaleit

  9. Rheumatologische Schwerpunktpraxis Erlangen, Möhrendorfer Str. 1c, Erlangen, Deutschland

    F. Schuch

  10. Rheumapraxis an der Hase, Osnabrück, Deutschland

    P. Steffens-Korbanka

Authors
  1. U. Kiltz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Sieper
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Backhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Buss
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Gromnica-Ihle
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Haíbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Hammel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K. Karberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S. Rehart
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Rudwaleit
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. F. Schuch
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. P. Steffens-Korbanka
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. J. Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to U. Kiltz.

Ethics declarations

Interessenkonflikt

Die Umfrage zum Konzept der SpA war anonymisiert. Die Befragung wurde durch die Firma Abbvie gesponsort. Eine inhaltliche Einflussnahme fand nicht statt. U. Kiltz, J. Sieper, M. Backhaus, B. Buss, E. Gromnica-Ihle, H. Haíbel, L. Hammel, K. Karberg, S. Rehart, M. Rudwaleit, F. Schuch, P. Steffens-Korbanka und J. Braun geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

U. Müller-Ladner, Bad Nauheim

U. Lange, Bad Nauheim

Caption Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kiltz, U., Sieper, J., Backhaus, M. et al. „Treat-to-target (T2T)“ Empfehlungen für die Behandlung von Patienten mit Spondyloarthritis – Übersetzung ins Deutsche. Z Rheumatol 75, 903–909 (2016). https://doi.org/10.1007/s00393-016-0124-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-016-0124-0

Schlüsselwörter

Keywords

Search

Navigation